Personalized Treatment Plans Every patient is different, which is why our board-certified physicians carefully evaluate your health history, current conditions, and weight loss goals before recommending any medication
Micronized progesterone, which more closely mirrors the molecular structure of the body's own progesterone, has largely replaced the older synthetic progestins used in the original WHI trial, and appears to offer improved tolerability and a more favorable safety profile [11,27]
When used alongside diet and exercise changes those on Semaglutide GLP-1 have higher weight loss percentages than those who just use diet and exercise alone and carry long-term health improvements by aiding your lifestyle changes
Going too long between doses could lead to a return of cravings, elevated glucose, or loss of therapeutic benefit
Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease
The LEADER trial showed that liraglutide reduced the risk of major cardiovascular events in people with type 2 diabetes.[4] Soon after, SUSTAIN-6 demonstrated similar benefits with semaglutide.[5] Then came REWIND, which suggested that cardiovascular protection could extend even to patients without established cardiovascular disease.[6] The SELECT trial made headlines because it showed cardiovascular benefits in people with overweight or obesity who did not have diabetes, a finding that challenged long-held assumptions about who might benefit from these medicines.[7] Most recently, an international trial called SOUL, which tested an oral form of semaglutide, included 788 Indian patients across 32 centres
